Transcat (NASDAQ:TRNS) Earns “Buy” Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Transcat (NASDAQ:TRNS) in a report published on Wednesday morning,Benzinga reports. HC Wainwright currently has a $116.00 price target on the scientific and technical instruments company’s stock. HC Wainwright also issued estimates for Transcat’s Q1 2026 earnings at $0.37 EPS, Q2 2026 earnings at $0.43 EPS, Q3 2026 earnings at $0.38 EPS, Q4 2026 earnings at $0.69 EPS and FY2026 earnings at $1.87 EPS.

Separately, Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a research note on Wednesday, May 28th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $114.00.

Transcat Price Performance

Shares of TRNS opened at $84.82 on Wednesday. The stock has a market capitalization of $790.52 million, a P/E ratio of 54.37 and a beta of 0.75. Transcat has a twelve month low of $67.56 and a twelve month high of $147.12. The company has a 50 day moving average of $82.59 and a 200-day moving average of $85.69. The company has a quick ratio of 1.87, a current ratio of 2.29 and a debt-to-equity ratio of 0.11.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.66 by ($0.02). The business had revenue of $77.13 million for the quarter, compared to the consensus estimate of $76.40 million. Transcat had a return on equity of 6.47% and a net margin of 5.21%. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities research analysts forecast that Transcat will post 2.3 EPS for the current fiscal year.

Institutional Investors Weigh In On Transcat

Large investors have recently made changes to their positions in the stock. Centiva Capital LP boosted its holdings in shares of Transcat by 6.0% in the 4th quarter. Centiva Capital LP now owns 3,009 shares of the scientific and technical instruments company’s stock valued at $318,000 after buying an additional 171 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Transcat by 0.6% in the 1st quarter. Bank of New York Mellon Corp now owns 27,916 shares of the scientific and technical instruments company’s stock valued at $2,078,000 after buying an additional 172 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Transcat by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,137 shares of the scientific and technical instruments company’s stock valued at $543,000 after buying an additional 194 shares during the last quarter. Diamond Hill Capital Management Inc. boosted its holdings in shares of Transcat by 3.4% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 6,353 shares of the scientific and technical instruments company’s stock valued at $473,000 after buying an additional 210 shares during the last quarter. Finally, US Bancorp DE boosted its holdings in shares of Transcat by 14.6% in the 1st quarter. US Bancorp DE now owns 1,770 shares of the scientific and technical instruments company’s stock valued at $132,000 after buying an additional 226 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.